Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John B. Copley is active.

Publication


Featured researches published by John B. Copley.


Transplantation | 2005

Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation : A randomized placebo controlled trial

Daniel A. Shoskes; Chantale Lapierre; Marcia Cruz-Corerra; Nicolas Muruve; Reinaldo Rosario; Beth Fromkin; Mauro Braun; John B. Copley

Background. The bioflavonoids quercetin and curcumin are renoprotective natural antioxidants. We wished to examine their effects on early graft function (EF). Methods. Between September 2002 and August 2004, 43 dialysis dependent cadaveric kidney recipients were enrolled into a study using Oxy-Q which contains 480 mg of curcumin and 20 mg of quercetin, started after surgery and taken for 1 month. They were randomized into three groups: control (placebo), low dose (one capsule, one placebo) and high dose (two capsules). Delayed graft function (DGF) was defined as first week dialysis need and slow function (SGF) as Cr >2.5 mg/dl by day 10. Category variables were compared by chi squared and continuous variables by Kruskal-Wallis. Results. There were four withdrawals: one by patient choice and three for urine leak. The control group had 2/14 patients with DGF vs. none in either treatment group. Incidence of EF was control 43%, low dose 71% and high dose 93% (P=0.013). Serum creatinine was significantly lower at 2 days (control 7.6±2.1, low 5.4±0.6, high 3.96±.35 P=0.0001) and 30 days (control 1.82±.16, low 1.65±.09, high 1.33 ±.1, P=0.03). Acute rejection incidence within 6 months was control 14.3%, low dose 14.3% and high dose 0%. Tremor was detected in 13% of high dose patients vs. 46% of others. Urinary HO-1 was higher in bioflavonoid groups. Conclusion. Bioflavonoid therapy improved early graft function. Acute rejection and neurotoxicity were lowest in the high dose group. These bioflavonoids improve early outcomes in cadaveric renal transplantation, possibly through HO-1 induction.


Obesity Surgery | 2005

Renal Failure, Glomerulonephritis and Morbid Obesity: Improvement after Rapid Weight Loss following Laparoscopic Gastric Bypass

Flavia Soto; Guillermo Higa-Sansone; John B. Copley; Mariana Berho; Colleen Kennedy; Emanuelle LoMenzo; David Podkameni; Samuel Szomstein; Raul J. Rosenthal

There is experimental evidence but very few human studies that suggest a role for obesity in the formation and progression of some glomerular lesions. We report the case of a morbidly obese male with hematuria and proteinuria that was subsequently diagnosed with renal failure which required dialysis. Histological findings of the renal biopsy performed during a laparoscopic gastric bypass are presented. His renal failure resolved with the weight loss.


Clinical Transplantation | 2011

Therapeutic management of post-kidney transplant hyperparathyroidism.

John B. Copley; Rudolf P. Wüthrich

Copley JB, Wüthrich RP. Therapeutic management of post‐kidney transplant hyperparathyroidism.
Clin Transplant 2011: 25: 24–39.


Transplantation | 1999

Prednisone withdrawal, in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study

Nasimul Ahsan; Donald E. Hricik; Arthur J. Matas; Stephen Rose; Stephen J. Tomlanovich; Alan H. Wilkinson; Marian Ewell; Matthew McIntosh; Donald Stablein; Ernest Hodge; Daniel Hayes; Paul F. Gores; David Cohen; Thomas A. Gonwa; Karl Brinler; Robert C. Harland; John F. Neylan; Mark D. Pescovitz; James J. Wynn; Harold C-Yang; William M. Bennett; John B. Copley; John Dunn; S. Tomlanovich; Lawrence Chan; J. Andrew Bertolatus; Mathew Weir; Robert Mendez; John D. Pirsch; J. Harold Helderman


American Journal of Kidney Diseases | 2005

Renal fibromuscular dysplasia in elderly persons

Amaryllis Pascual; Howard S. Bush; John B. Copley


Dm Disease-a-month | 2005

Hypertension: a review and rationale of treatment.

John B. Copley; Reinaldo Rosario


Transplantation Proceedings | 2003

Phase I study of oral bioflavonoids in cadaveric renal transplant recipients: Effects on delayed graft function and calcineurin inhibitor toxicities

Daniel A. Shoskes; M. Thomas; R. Pobgee; Beth Fromkin; John B. Copley


Journal of Clinical Hypertension | 2006

Optimizing Hypertension Control in Patients With Multiple Cardiovascular Risk Factors

John B. Copley


American Journal of Kidney Diseases | 2007

160: Chronic Kidney Disease (CKD) in Patients With Nephrolithiasis: Expanded Data

Rute Paixao; Mauro Braun; John B. Copley; Beth Fromkin; Arun Amatya


Transplantation | 2006

Erratum: Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: A randomized placebo controlled trial (Transplantation (December 15, 2005) 80, 11 (1556-1559))

Daniel A. Shoskes; Chantale Lapierre; Marcia Cruz-Correa; Nicolas Muruve; Reinaldo Rosario; Beth Fromkin; Mauro Braun; John B. Copley

Collaboration


Dive into the John B. Copley's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge